DK1221438T3 - Salts of Amlodipine Mesylate - Google Patents

Salts of Amlodipine Mesylate

Info

Publication number
DK1221438T3
DK1221438T3 DK01129690T DK01129690T DK1221438T3 DK 1221438 T3 DK1221438 T3 DK 1221438T3 DK 01129690 T DK01129690 T DK 01129690T DK 01129690 T DK01129690 T DK 01129690T DK 1221438 T3 DK1221438 T3 DK 1221438T3
Authority
DK
Denmark
Prior art keywords
weak
degrees
modification
amlodipine mesylate
salts
Prior art date
Application number
DK01129690T
Other languages
Danish (da)
Inventor
Ralf Dr Hoss
Michael Oelting
Beat W Dr Mueller
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Application granted granted Critical
Publication of DK1221438T3 publication Critical patent/DK1221438T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Two crystal modifications of amlodipine mesylate are new. Two new crystal modifications of amlodipine mesylate are: (a) modification A of m.pt. 184 plus or minus 4 degrees C and peaks at 6.6 (very strong), 10.2 (weak), 11.0 (very strong), 14.7 (weak) and 15.9 (average) degrees 2 Theta in the powder X-ray diagram; and (b) modification B with m.pt. 145 3 degrees C and peaks at 3.8 (very weak), 7.5 (average), 11.3 (very strong), 12.5 (weak), 14.4 (weak) and 15.1 (weak) degrees 2 Theta in the powder X-ray diagram. Independent claims are also included for the preparation of anhydrous modification A and of modification B.
DK01129690T 2001-01-09 2001-12-13 Salts of Amlodipine Mesylate DK1221438T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH222001 2001-01-09

Publications (1)

Publication Number Publication Date
DK1221438T3 true DK1221438T3 (en) 2007-06-18

Family

ID=4228649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01129690T DK1221438T3 (en) 2001-01-09 2001-12-13 Salts of Amlodipine Mesylate

Country Status (4)

Country Link
EP (1) EP1221438B1 (en)
AT (1) ATE356806T1 (en)
DE (1) DE50112189D1 (en)
DK (1) DK1221438T3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100538641B1 (en) * 2002-07-30 2005-12-22 씨제이 주식회사 An organic acid salt of amlodipine
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
WO2004096770A1 (en) * 2003-04-25 2004-11-11 Cipla Limited Process for preparing almodipine mesylate monohydrate
CN112538044B (en) * 2019-12-09 2021-08-13 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, and preparation method and application thereof
US20230023131A1 (en) * 2019-12-09 2023-01-26 Kunming Sinoway Natural Pharmaceuticals Co., Ltd. Amlodipine mesylate monohydrate preparation method therefor and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
PL189666B1 (en) * 1998-04-09 2005-09-30 Adamed Sp Z Oo Method of obtaining amlopidine benzenosulphonate
CN1091441C (en) * 1999-12-04 2002-09-25 昆明赛诺制药有限公司 Amlo dipine mesylate and its preparation and application

Also Published As

Publication number Publication date
EP1221438B1 (en) 2007-03-14
EP1221438A3 (en) 2003-10-08
EP1221438A2 (en) 2002-07-10
ATE356806T1 (en) 2007-04-15
DE50112189D1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
DE60234409D1 (en) Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive composition
AU2003240054A1 (en) Photonic switch working in momentum-divison-multiple-access (mdma) mode for microwave and optical wavelengths based upon the measurement of the spin, the orbital angular momentum and the total angular momentum of the involved photo
DE60209779D1 (en) SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
IS2217B (en) Tatrate salts of 5,8,14, -triasate tetracyclo [10.3.1.02, 11.04.9] -hexadeca-2 (11), 3,5,7,8, -pentaene.
ITPD990279A0 (en) IMPROVED TRIPOD, ESPECIALLY FOR OPTICAL AND PHOTOGRAPHER USES.
ATE416771T1 (en) N-Ä4-(4-AMINO-2-ETHYL-1H-IMIDAZOÄ4,5-CUCHINOLINE 1-YL)BUTYLUMETHANESULFONAMIDE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF
DE60112974D1 (en) Carbolinderivate
ITRM20030521A1 (en) SUBSIDY LOCKING PROCEDURE THROUGH THE ETHER.
ATE302782T1 (en) SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO(4,5)DEC-2-EN DERIVATIVES AS MEDICINAL AGAINST PAIN
ES2110375T3 (en) NIMESULIDE FOR EXTERNAL USE.
NO20035333D0 (en) New ligand for nicotinic acetylcholine receptors useful in therapy
ATE209899T1 (en) SOLID, RAPIDLY DISSOLVING CETIRIZINE FORMULATIONS
DE60216233D1 (en) Carbolinderivate
DK1736158T3 (en) Use of 1- 4- (5-cyanoindol-3-yl) butyl -4- (2-carbamoylbenzofuran-5-yl) piperazine and the physiologically acceptable salts thereof
NO20012727D0 (en) 3,4,5-trisubstituted arylnitron compounds and pharmaceutical compositions containing the same
DK1221438T3 (en) Salts of Amlodipine Mesylate
NO20040404L (en) 2- (3,5-Bis-trifluoromethyl-phenyl) -N- [6- (1,1-dioxo-1am-bda6-thiomorpholin-4-yl) -4- (2-methyl- or 4-fluoro-2- methyl substituted) phenyl-pyridin-3-yl] -N-methyl-isobutyramine.
DE69817995D1 (en) Flexible, foldable blood bag
DE60120711D1 (en) ARYLETHENE SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS
DK1206256T3 (en) Combination treatment using pentafluorobenzene sulfonamide and platinum compound
DK1532141T3 (en) 2-Pyrrolidin-2-yl [1,3,4] oxadiazole derivatives and their use as antidepressants
ITMI20011117A0 (en) SEWING MACHINE WITH CUTTERS, WITH HIGH RELIABILITY AND OPERATIONAL PRECISION
AP2005003248A0 (en) 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of I. A. HIV.
DE60204888D1 (en) ROTATING STAND TOOL FOR CONTINUOUS PUNCHING OF PROFILES AND USE THEREOF
ES1048822Y (en) PERFECTED FOLDABLE TABLE.